文献速递乳腺乳腺X线

数字乳腺断层合成:在社区医疗保健机构中使用私人保险和联邦医疗保险的成本效益

Digital Breast Tomosynthesis: Cost-Effectiveness of Using Private and Medicare Insurance in Community-Based Health Care Facilities.
PubMed 文献 · AJR Am J Roentgenol · 2017-02-08

该回顾性数据分析纳入2013年7月15日至2014年7月14日期间接受筛查性乳腺X线摄影并包含任何额外放射学检查的女性6319例,其中3655例接受数字乳腺断层合成(DBT),2664例接受全视野数字乳腺X线摄影(FFDM)。标准化两组癌症检出率差异后,DBT对私人保险账单是成本等效的替代方案,但对联邦医疗保险成本而言则是成本低效的替代方案。

要点

  • DBT组每人费用较FFDM组高约40美元(私人保险和联邦医疗保险均如此)。
  • DBT组每检出1例癌症的成本在私人保险和联邦医疗保险下均低于FFDM组。
  • 标准化癌症检出率差异后,DBT对私人保险为成本等效,对联邦医疗保险为成本低效。

核心结论

  • 在社区环境中,DBT是FFDM的成本等效或潜在成本有效的替代方案,并具有改善癌症检出率和召回率的能力。

研究设计与样本

  • 回顾性数据分析,纳入2013年7月15日至2014年7月14日期间接受筛查性乳腺X线摄影并包含任何额外放射学检查的女性6319例;患者根据个人偏好、医生建议和费用差异选择DBT或FFDM;以1年期间发现结果的总和计算召回率、癌症检出率及地区私人保险和联邦医疗保险的账单费用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to determine whether digital breast tomosynthesis (DBT) is a cost-effective alternative to full-field digital mammography (FFDM) for both Medicare and privately insured patients undergoing screening mammography.

MATERIALS AND METHODS: A retrospective data analysis was performed between July 15, 2013, and July 14, 2014, with data on women presenting for screening mammography that included any additional radiologic workup (n = 6319). Patients chose to undergo DBT or FFDM on the basis of personal preference, physician suggestion, and cost difference. The summation of findings over the 1-year period were used to calculate recall rates, cancer detection rates, and billing costs for a regional private insurer and Medicare.

RESULTS: Data from the 6319 patients who participated were divided: 3655 patients underwent DBT, and 2664 underwent FFDM during the year of screening. Private insurance billing cost $2.9 million, and Medicare cost $1.2 million for screening, follow-up imaging, and radiologic procedures. Per-person costs were approximately $40 higher for the DBT group using both forms of insurance. However, cost per cancer detected was lower in the DBT group for both private and governmental insurance, leading to potentially $3.7 million and $899,000 saved per 100 cancers found. After standardization of the difference in cancer detection rates between the two groups, DBT was a cost-equivalent alternative to FFDM for private insurance billing but was a cost-inefficient alternative with respect to Medicare costs.

CONCLUSION: In a community-based setting, DBT is a cost-equivalent or potentially cost-effective alternative to FFDM and has the capacity for improving cancer detection and recall rates.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Hunter SA, Morris C, Nelson K, et al. Digital Breast Tomosynthesis: Cost-Effectiveness of Using Private and Medicare Insurance in Community-Based Health Care Facilities. AJR Am J Roentgenol. 2017. PMID: 28177646. doi:10.2214/AJR.16.16987

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。